On September 29, 2026, China Pharmaceutical Company Limited acquired 1.50 million shares of SSY GROUP (02005) off-exchange at an average of HKD 2.7812 per share, involving about HKD 4.17 million. This was an off-exchange transaction, not matched on the SEHK open market and therefore not a direct secondary-market dealing.
Prior to the acquisition, China Pharmaceutical Company Limited's long position in SSY GROUP was 923.20 million shares, representing 31.28%; following the acquisition, the holding changed to 924.70 million shares, with the long position ratio rising to 31.33%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments